Cargando…
Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2
Dlx2, Lymphoid Enhancer Factor (Lef-1) and Msx2 transcription factors are required for several developmental processes. To understand the control of gene expression by these factors, chromatin immunoprecipitation (ChIP) assays identified Msx2 as a downstream target of Dlx2 and Lef-1. Dlx2 activates...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1635299/ https://www.ncbi.nlm.nih.gov/pubmed/17068080 http://dx.doi.org/10.1093/nar/gkl689 |
_version_ | 1782130681375096832 |
---|---|
author | Diamond, Evan Amen, Melanie Hu, Qiaoyan Espinoza, Herbert M. Amendt, Brad A. |
author_facet | Diamond, Evan Amen, Melanie Hu, Qiaoyan Espinoza, Herbert M. Amendt, Brad A. |
author_sort | Diamond, Evan |
collection | PubMed |
description | Dlx2, Lymphoid Enhancer Factor (Lef-1) and Msx2 transcription factors are required for several developmental processes. To understand the control of gene expression by these factors, chromatin immunoprecipitation (ChIP) assays identified Msx2 as a downstream target of Dlx2 and Lef-1. Dlx2 activates the Msx2 promoter in several cell lines and binds DNA as a monomer and dimer. A Lef-1 β-catenin-dependent isoform minimally activates the Msx2 promoter and a Lef-1 β-catenin-independent isoform is inactive, however co-expression of Dlx2 and both Lef-1 isoforms synergistically activate the Msx2 promoter. Co-immunoprecipitation and protein pull-down experiments demonstrate Lef-1 physically interacts with Dlx2. Deletion analyses of the Lef-1 protein reveal specific regions required for synergism with Dlx2. The Lef-1 β-catenin binding domain (βDB) is not required for its interaction with Dlx2. Msx2 can auto-regulate its promoter and repress Dlx2 activation. Msx2 repression of Dlx2 activation is dose-specific and both bind a common DNA-binding element. These transcriptional mechanisms correlate with the temporal and spatial expression of these factors and may provide a mechanism for the control of several developmental processes. We demonstrate new transcriptional activities for Dlx2, Msx2 and Lef-1 through protein interactions and identification of downstream targets. |
format | Text |
id | pubmed-1635299 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-16352992006-12-26 Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2 Diamond, Evan Amen, Melanie Hu, Qiaoyan Espinoza, Herbert M. Amendt, Brad A. Nucleic Acids Res Molecular Biology Dlx2, Lymphoid Enhancer Factor (Lef-1) and Msx2 transcription factors are required for several developmental processes. To understand the control of gene expression by these factors, chromatin immunoprecipitation (ChIP) assays identified Msx2 as a downstream target of Dlx2 and Lef-1. Dlx2 activates the Msx2 promoter in several cell lines and binds DNA as a monomer and dimer. A Lef-1 β-catenin-dependent isoform minimally activates the Msx2 promoter and a Lef-1 β-catenin-independent isoform is inactive, however co-expression of Dlx2 and both Lef-1 isoforms synergistically activate the Msx2 promoter. Co-immunoprecipitation and protein pull-down experiments demonstrate Lef-1 physically interacts with Dlx2. Deletion analyses of the Lef-1 protein reveal specific regions required for synergism with Dlx2. The Lef-1 β-catenin binding domain (βDB) is not required for its interaction with Dlx2. Msx2 can auto-regulate its promoter and repress Dlx2 activation. Msx2 repression of Dlx2 activation is dose-specific and both bind a common DNA-binding element. These transcriptional mechanisms correlate with the temporal and spatial expression of these factors and may provide a mechanism for the control of several developmental processes. We demonstrate new transcriptional activities for Dlx2, Msx2 and Lef-1 through protein interactions and identification of downstream targets. Oxford University Press 2006-11 2006-11-26 /pmc/articles/PMC1635299/ /pubmed/17068080 http://dx.doi.org/10.1093/nar/gkl689 Text en © 2006 The Author(s) |
spellingShingle | Molecular Biology Diamond, Evan Amen, Melanie Hu, Qiaoyan Espinoza, Herbert M. Amendt, Brad A. Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2 |
title | Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2 |
title_full | Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2 |
title_fullStr | Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2 |
title_full_unstemmed | Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2 |
title_short | Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2 |
title_sort | functional interactions between dlx2 and lymphoid enhancer factor regulate msx2 |
topic | Molecular Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1635299/ https://www.ncbi.nlm.nih.gov/pubmed/17068080 http://dx.doi.org/10.1093/nar/gkl689 |
work_keys_str_mv | AT diamondevan functionalinteractionsbetweendlx2andlymphoidenhancerfactorregulatemsx2 AT amenmelanie functionalinteractionsbetweendlx2andlymphoidenhancerfactorregulatemsx2 AT huqiaoyan functionalinteractionsbetweendlx2andlymphoidenhancerfactorregulatemsx2 AT espinozaherbertm functionalinteractionsbetweendlx2andlymphoidenhancerfactorregulatemsx2 AT amendtbrada functionalinteractionsbetweendlx2andlymphoidenhancerfactorregulatemsx2 |